• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAT-582(AS-5370的R对映体)的5-羟色胺3型受体拮抗剂作用

5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.

作者信息

Yoshida N, Omoya H, Kato S, Ito T

机构信息

Exploratory Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Suita/Osaka, Japan.

出版信息

Eur J Pharmacol. 1992 Jun 17;216(3):435-40. doi: 10.1016/0014-2999(92)90442-7.

DOI:10.1016/0014-2999(92)90442-7
PMID:1425931
Abstract

The serotonin 5-HT3 receptor antagonist effects of DAT-582, the (R) enantiomer of AS-5370 ((+/-)-N-[1-methyl-4-(3-methyl-benzyl)hexahydro-1H-1,4-diazepin-6- yl]-1H- indazole-3-carboxamide dihydrochloride), and its antipode were compared with those of AS-5370 and existing 5-HT3 receptor antagonists. In anesthetized rats, DAT-582 antagonized 2-methyl-5-HT-induced bradycardia with an ED50 value of 0.25 microgram/kg i.v., whereas the (S) enantiomer was without effect even at 1000 micrograms/kg i.v. In antagonizing the bradycardia, DAT-582 was as potent as granisetron, slightly more potent than AS-5370, and 2, 5 and 18 times more potent than ondansetron, ICS 205-903 and renzapride, respectively, although it was less potent than zacopride. DAT-582 inhibited cisplatin (10 mg/kg i.v.)-induced emesis in ferrets with an ED50 value of 3.2 micrograms/kg i.v. twice. The antiemetic activity of DAT-582 was more potent than that of the existing 5-HT3 receptor antagonists examined, except zacopride. In contrast, the (S) enantiomer had little effect at 1000 micrograms/kg i.v. twice. In isolated guinea-pig ileum, DAT-582 inhibited 5-HT-induced contractions with an IC50 value of 91 nM, whereas the (S) enantiomer hardly inhibited them even at 1000 nM. These results suggest that DAT-582, the (R) enantiomer of AS-5370, potently and selectively blocks 5-HT3 receptors.

摘要

比较了AS-5370((±)-N-[1-甲基-4-(3-甲基苄基)六氢-1H-1,4-二氮杂卓-6-基]-1H-吲唑-3-甲酰胺二盐酸盐)的(R)对映体DAT-582及其对映体与AS-5370和现有5-HT3受体拮抗剂的5-羟色胺5-HT3受体拮抗作用。在麻醉大鼠中,DAT-582拮抗2-甲基-5-HT诱导的心动过缓,静脉注射ED50值为0.25微克/千克,而(S)对映体即使在静脉注射1000微克/千克时也无作用。在拮抗心动过缓方面,DAT-582与格拉司琼效力相当,比AS-5370稍强,分别比昂丹司琼、ICS 205-903和瑞扎曲普坦强2倍、5倍和18倍,尽管其效力低于扎考必利。DAT-582抑制雪貂顺铂(静脉注射10毫克/千克)诱导的呕吐,静脉注射ED50值为3.2微克/千克,给药两次。DAT-582的止吐活性比所检测的现有5-HT3受体拮抗剂(扎考必利除外)更强。相比之下,(S)对映体在静脉注射1000微克/千克、给药两次时几乎没有作用。在离体豚鼠回肠中,DAT-582抑制5-HT诱导的收缩,IC50值为91 nM,而(S)对映体即使在1000 nM时也几乎不抑制。这些结果表明,AS-5370的(R)对映体DAT-582能有效且选择性地阻断5-HT3受体。

相似文献

1
5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.DAT-582(AS-5370的R对映体)的5-羟色胺3型受体拮抗剂作用
Eur J Pharmacol. 1992 Jun 17;216(3):435-40. doi: 10.1016/0014-2999(92)90442-7.
2
DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.DAT-582是一种新型5-羟色胺3受体拮抗剂,在雪貂和狗身上是一种强效且持久的止吐药。
J Pharmacol Exp Ther. 1992 Mar;260(3):1159-65.
3
The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.新型多巴胺D2、D3和5-羟色胺3(5-HT3)受体拮抗剂AS-8112的广谱止吐活性
Br J Pharmacol. 2001 May;133(2):253-60. doi: 10.1038/sj.bjp.0704078.
4
Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.介导豚鼠离体回肠收缩的5-羟色胺3型和“非典型”5-羟色胺受体的特性研究
Br J Pharmacol. 1990 Nov;101(3):513-20. doi: 10.1111/j.1476-5381.1990.tb14113.x.
5
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.强效选择性拮抗剂RS 25259-197与5-HT3受体在体外的相互作用。
Br J Pharmacol. 1995 Feb;114(4):851-9. doi: 10.1111/j.1476-5381.1995.tb13282.x.
6
(R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity.(R)和(S)RS 56532:具有相反对映体选择性的5-羟色胺3型和5-羟色胺4型受体混合配体。
Neuropharmacology. 1994 Mar-Apr;33(3-4):515-26. doi: 10.1016/0028-3908(94)90083-3.
7
Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.4,5,6,7-四氢苯并咪唑衍生物对5-羟色胺(5-HT)诱导的麻醉大鼠心动过缓的5-羟色胺(5-HT)3受体拮抗作用。
Jpn J Pharmacol. 1994 Jul;65(3):241-8. doi: 10.1254/jjp.65.241.
8
Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.ICS 205-930、GR38032F和扎考必利对5-羟色胺3受体的拮抗特性比较。
J Pharmacol Exp Ther. 1989 Jan;248(1):197-201.
9
Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
J Pharmacol Exp Ther. 1991 Nov;259(2):815-9.
10
Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.新合成的二氮杂双环衍生物N-3389对5-HT3和5-HT4受体的拮抗活性。
Eur J Pharmacol. 1994 Dec 12;271(1):159-66. doi: 10.1016/0014-2999(94)90276-3.

引用本文的文献

1
Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.顺铂诱导的呕吐:雪貂模型的系统评价和荟萃分析及 5-HT₃受体拮抗剂的作用。
Cancer Chemother Pharmacol. 2011 Mar;67(3):667-86. doi: 10.1007/s00280-010-1339-4. Epub 2010 May 28.
2
Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.瑞扎普明的药理学与代谢:一种用于潜在治疗肠易激综合征的新型治疗药物。
Drugs R D. 2008;9(1):37-63. doi: 10.2165/00126839-200809010-00004.
3
The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
新型多巴胺D2、D3和5-羟色胺3(5-HT3)受体拮抗剂AS-8112的广谱止吐活性
Br J Pharmacol. 2001 May;133(2):253-60. doi: 10.1038/sj.bjp.0704078.